Clinical Trials Directory

Trials / Completed

CompletedNCT05713981

The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression

The Impact of Dry Eye Syndrome on Novel Metrics of Low Contrast Vision Before and After Therapeutic Meibomian Gland Expression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of the Incarnate Word · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study aims to determine the impact of Meibomian Gland Dysfunction (MGD) dry eye on low contrast black/white (luminance) and cone color sensitivity performance and improvement in these functions after in-house non-invasive Meibomian gland (MG) expression.

Detailed description

This study offers possible benefits from gland expression to patients and subjects in terms of clinical measurements and care associated with meibomian gland dysfunction impacting all age ranges. Prior studies show that these interventions improve dry eye symptoms with intent to improve vision, low contrast color, and B/W vision after intervention in this study.

Conditions

Interventions

TypeNameDescription
PROCEDUREMeibomian gland (MG) expressionThe procedure is performed with a sterile cotton tip applicator once in the upper and lower eyelids of the subject's choosing.

Timeline

Start date
2023-03-01
Primary completion
2023-06-08
Completion
2023-06-08
First posted
2023-02-06
Last updated
2023-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05713981. Inclusion in this directory is not an endorsement.